Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Ebiomedicine|March 2, 2020
FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacyÁlvaro Quintanal-Villalonga, Irene Ferrer, Elizabeth Guruceaga, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2016
IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF)Maria Delores Pastor, Ana Nogal, Sonia Molina-Pinelo, et al.
Oncotarget|December 30, 2017
Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancerEva M Verdugo-Sivianes, Lola Navas, Sonia Molina-Pinelo, et al.
HIV Medicine|August 7, 2025
Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control studyGeorg M N Behrens, Lambert Assoumou, Stephane De Wit, et al.
Plos One|March 15, 2014
MicroRNA-dependent regulation of transcription in non-small cell lung cancerSonia Molina-Pinelo, Gabriel Gutiérrez, Maria Dolores Pastor, et al.
The Journal of Biological Chemistry|August 20, 2009
Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinasesWolfgang Link, Julen Oyarzabal, Beatriz G Serelde, et al.
Plos One|July 24, 2026
Correction: Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapyJose-Ramon Blanco, Miguel Torralba, María Saumoy, et al.
BMC Cancer|September 9, 2014
MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancerSonia Molina-Pinelo, Amancio Carnero, Fernando Rivera, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 5, 2019
New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic toolsSandra Muñoz-Galván, Blanca Felipe-Abrio, Miguel García-Carrasco, et al.
Signal Transduction and Targeted Therapy|October 24, 2023
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2AJavier Martin-Broto, Jeronimo Martinez-Garcia, David S Moura, et al.
Pageof 19